Data driven curated intelligence reports and analytics
Comprehensive pharmaceutical intelligence delivered monthly and quarterly. Transform weeks of manual research into strategic insights with our expert-curated reports powered by GPI’s Pulse platform.
Driving pharmaceutical success through strategic intelligence
Why clients choose us
- Transform weeks to minutes: decision-ready insights delivered
- Access one source of truth: unified data across all markets
- Simplify compliance globally: U.S. and international requirements
- Stay ahead of competitors: real-time intelligence and insights
- Choose flexible delivery: modular, adaptable reporting solutions
Global & U.S. pricing tracking
Comprehensive pharmaceutical pricing intelligence
Track historical and real-time pricing changes, benchmark across countries, and consolidate U.S. price types in one comprehensive view. Stay ahead of market movements with automated monitoring and comprehensive coverage across 100+ global pharmaceutical markets.
Our pricing intelligence delivers immediate insights on pharmaceutical pricing movements across therapeutic areas, enabling faster strategic decision-making with comprehensive market visibility and competitive benchmarking capabilities.
Core capabilities:
- Real-time monitoring with automated alerts for global pricing changes
- Multi-country benchmarking with consolidated U.S. pricing data
International reference pricing updates
IRP policy intelligence & risk management
Track IRP policy shifts and rule changes across 100+ markets to stay ahead of pricing risk. Monitor cross-market dependencies and policy impacts to protect your global pharmaceutical pricing strategy with comprehensive regulatory intelligence.
Key features:
IRP policy monitoring across global pharmaceutical markets
Cross-market dependency analysis and impact assessment
Risk identification with policy change notifications
Strategic planning support for IRP-related decisions
HTA updates & market access intelligence
Regulatory pathway intelligence
Condensed payer decision summaries across 30+ countries with rationale and access strategy implications. Understand regulatory pathways and evidence requirements for successful pharmaceutical market access.
Analytics capabilities:
HTA decision summaries with strategic implications
Regulatory pathway guidance and evidence requirements
Payer rationale analysis for market access planning
Access strategy recommendations across therapeutic areas
Analogue & competitive intelligence
Comprehensive competitor monitoring
Monitor competitor launch timelines, pricing strategies, and availability for lifecycle planning. Track competitive landscapes and identify market opportunities across therapy areas with comprehensive pharmaceutical intelligence.
Strategic tools:
Competitor launch timeline tracking and analysis
Pricing strategy monitoring across therapeutic areas
Availability tracking for competitive positioning
Market opportunity identification and assessment
Treatment cost & dosing reports
Cost-effectiveness intelligence suite
Pre-modelled cost reports for cost-effectiveness modelling and HTA submissions. Access standardised treatment cost analysis and dosing protocols designed for regulatory submissions and strategic pharmaceutical planning.
Extended features:
Treatment cost corridor analysis across indications
Dosing protocol intelligence for regulatory submissions
Cost-effectiveness modeling support tools
Reimbursement landscape visualisation and payer insights
Interactive intelligence approach
We thoroughly assess your current pharmaceutical landscape, taking into account both short, and long-term strategic objectives, therapeutic portfolio dynamics, and evolving market priorities. Our dedicated team of pharmaceutical experts supports you through every stage of the intelligence planning process and significant commercial milestones.
Integrated data, analytics & strategic guidance
Our comprehensive pharmaceutical intelligence combines proprietary data aggregation, advanced analytics, and strategic expertise to deliver actionable insights for pricing and market access decisions. We integrate over 200 data sources across 100+ global markets to provide unified pharmaceutical intelligence.
Key benefits:
Integrated data platform with real-time pharmaceutical market intelligence
Advanced analytics with AI-powered insights and predictive modeling
Strategic guidance from seasoned pharmaceutical pricing experts
Comprehensive coverage across therapeutic areas and global markets
Monthly & quarterly strategic intelligence delivery
Our expert-curated intelligence reports provide monthly and quarterly insights with analyst-driven strategic implications for pharmaceutical pricing and market access. Deep expertise combines technological capabilities with geographical knowledge across every pharmaceutical market globally.
Intelligence services:
Monthly pharmaceutical pricing tracking and market access reports
Quarterly competitive intelligence and strategic analysis
Expert-validated insights with strategic recommendations
Collaborative approach supporting long-term pharmaceutical partnerships
Drive pharmaceutical success with data-driven intelligence
Transform complex pharmaceutical pricing challenges into competitive advantages with GPI’s strategic partnership. We decode market complexities and deliver actionable intelligence that drives revenue growth across your therapeutic portfolio.
Global pharmaceutical pricing intelligence
Market access & regulatory intelligence
Strategic advisory & expert consultation
Expand your pharmaceutical presence efficiently with comprehensive market intelligence and scalable solutions. From single-asset launches to global portfolio optimisation, GPI’s platform grows with your ambitions.
Launch sequence optimisation
Portfolio revenue maximisation
Scalable data infrastructure
Gain a competitive edge with in-depth market intelligence. We analyse your competitors’ strengths and weaknesses to position your business for sustainable advantage.
Real-time competitor monitoring
Competitive benchmarking & analysis
Competitor intelligence reports
GPI was able to provide a base-case and worst-case forecasts, as well as surrounding strategy for supporting indication optimisation to ensure maximum asset revenue
How can our pharmaceutical intelligence help you reach your strategic goals
Understanding
your challenges
Schedule a 30-minute call to discuss your goals and challenges. This initial consultation outlines our process and how we can help.
Intelligence
gathering
Meet our team to gather comprehensive market data to support your strategic intelligence needs across your portfolio.
Strategic
planning
Our specialists will present a personalised intelligence framework aligned with your portfolio strategy and provide clear implementation steps.
Ongoing
intelligence
Receive ongoing intelligence with actionable insights and recommendations, keeping your strategy up-to-date and competitive.
Michelle Pardo
GPI is always ready to listen, flexible, available and amenable to all business needs. Pfizer relies heavily on GPI’s Cost of Treatment calculations in order to determine which products we have to report on, and therefore upholding our reputation.
Marc Gauthier-Darnis
Major impact. As GPI is our only price database provider, we fully trust them… We’ve been working together for a while and GPI has always met our expectations and solved our problems if any.
